0% read

DNDi feted in Japan for developing treatments for neglected diseases

DNDi feted in Japan for developing treatments for neglected diseases

Carbonatix Pre-Player Loader

Audio By Carbonatix

The global not-for-profit medical research organisation Drugs for Neglected Diseases initiative (DNDi) has been awarded the fifth Hideyo Noguchi Africa Prize in the medical services category. This prestigious prize, awarded every three years, is the highest medical honour from the Government of Japan.

It was established in honour of the medical scientist Dr Hideyo Noguchi (1876-1928), who devoted his life to bacteriological research and died while studying yellow fever in Africa. DNDi has been recognised for its work in developing and delivering new treatments for neglected diseases.

"This recognition is proof of the power of a model for medical innovation driven purely by patients’ needs, where African scientists are leading the charge against diseases that have long burdened our communities," said Prof. Samuel Kariuki, DNDi Continental Lead Africa, and Eastern Africa Director.

‘DNDi was founded with the vision that Africa should not have to wait for others to solve our health challenges. We remain committed to ensuring that no disease is overlooked simply because it affects the poorest and most vulnerable.’

DNDi was co-founded in 2003 by the Kenya Medical Research Institute (KEMRI) and other global partners. Over the past 22 years, it has become a model for African-led health innovation, developing 13 new treatments for six deadly diseases, 9 of which were delivered from Africa.

DNDi's work spans the continent, with clinical trials conducted with partners in countries including the Central African Republic, the Democratic Republic of Congo (DRC), Ethiopia, Guinea, Kenya, Malawi, Tanzania, and Uganda. It delivered fexinidazole, the first-ever all-oral treatment for both the gambiense and rhodesiense forms of sleeping sickness. It has also conducted the world's first randomised clinical trial for mycetoma, carried out numerous clinical studies for improved leishmaniasis treatments, and developed new treatments for children with HIV.

As one of DNDi’s founding partners, KEMRI is immensely proud to see DNDi recognised for its outstanding contributions, and for our shared commitment to addressing neglected diseases, said Prof Elijah Songok, Director General, KEMRI.

Songok added that the award demonstrates the impact of research initiatives led by African institutions.

latest stories

Tags:

Japan KEMRI DNDi

Want to send us a story? SMS to 25170 or WhatsApp 0743570000 or Submit on Citizen Digital or email wananchi@royalmedia.co.ke

Leave a Comment

Comments

No comments yet.